To be clear: No evidence has emerged of GLP-1s causing health problems on a large scale (though some studies have linked a few fatalities to hypoglycemia that emerged after using GLP-1s or an increased risk of pancreatitis or bowel obstruction)
If nausea is significant, your dose may need to increase more slowly
Real-world evidence (Nature, 2023) A survey of 153 adults with obesity who were already taking semaglutide or tirzepatide found they reported a 73% reduction in weekly alcohol consumption, and their likelihood of binge-drinking dropped by about 80% compared to similar people not on medication
Some influencers try to sidestep the rules by referring to the drug as a research chemical or citing it as not for human consumption
Person B loses 40 pounds of fat and 20 pounds of muscle
Their impact on weight loss and cardiovascular health could also contribute to better overall respiratory outcomes. These findings may encourage doctors to prioritize SGLT-2i or GLP-1RAs over DPP-4i for patients with type 2 diabetes and COPD, Ray said
